Cargando…
EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease
Huntington disease (HD) is caused by the expansion of an unstable polymorphic trinucleotide (CAG)n repeat in exon 1 of the HTT gene, which translates into an extended polyglutamine tract in the protein. Laboratory diagnosis of HD involves estimation of the number of CAG repeats. Molecular genetic te...
Autores principales: | Losekoot, Monique, van Belzen, Martine J, Seneca, Sara, Bauer, Peter, Stenhouse, Susan A R, Barton, David E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641377/ https://www.ncbi.nlm.nih.gov/pubmed/22990145 http://dx.doi.org/10.1038/ejhg.2012.200 |
Ejemplares similares
-
EMQN best practice guidelines for genetic testing in dystrophinopathies
por: Fratter, Carl, et al.
Publicado: (2020) -
EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
por: Baumgartner-Parzer, Sabina, et al.
Publicado: (2020) -
EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH)
por: Porto, Graça, et al.
Publicado: (2016) -
EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies
por: Traeger-Synodinos, Joanne, et al.
Publicado: (2015) -
Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes
por: Beygo, Jasmin, et al.
Publicado: (2019)